Tổng quan các công cụ tự báo cáo đo lường tuân thủ thuốc hít của người bệnh phổi tắc nghẽn mạn tính

Chronic obstructive pulmonary disease (COPD) remains a significant global health challenge, profoundly affecting patients' quality of life and demanding long-term management, often involving inhaled medications. However, the effectiveness of this treatment is critically dependent on high inhaler adherence, which encompasses not only correct dosing and timing but also proper inhalation technique. Current adherence rates for COPD patients are notably low, leading to suboptimal treatment outcomes, increased healthcare utilization, and higher costs. Recognizing the complex interplay of factors influencing adherence, this study aims to synthesize and evaluate various self-report tools for measuring inhaler adherence in individuals with chronic obstructive pulmonary disease, with a specific focus on their feasibility, reliability, and applicability within the Vietnamese clinical setting, ultimately proposing suitable instruments for local practice.

Healthcare professionals (physicians, nurses, pharmacists), clinical researchers, and public health practitioners focused on respiratory medicine, chronic disease management, and patient adherence, especially those working in or interested in the Vietnamese healthcare system.

This systematic review comprehensively evaluated self-report instruments designed to measure inhaler adherence among patients with chronic obstructive pulmonary disease (COPD), specifically considering their feasibility, reliability, and applicability in the Vietnamese context. Adhering to PRISMA (2020) guidelines, a meticulous literature search was conducted across major databases including PubMed, Europe PMC, Google Scholar, and Dimensions for studies published between 2015 and 2024. Eligible studies focused on self-report tools assessing inhaler adherence and reported relevant measurement properties, with data rigorously extracted and appraised using the COSMIN framework, ensuring a robust analysis of reliability, validity, applicability, and responsiveness. Out of 11 studies meeting inclusion criteria, five specifically evaluated the Test of Adherence to Inhalers (TAI). Other identified tools included CMAAS-12, MARS, MAR-Scale, SPUR-27, IMAS, and V-IUS. The findings highlight that TAI demonstrated high reliability and was effective in differentiating between adherent and non-adherent patients, while also crucially identifying inhaler technique errors—a critical yet often overlooked aspect. Concurrently, the Inhaler Medication Adherence Scale (IMAS), grounded in the theory of planned behavior, offered a comprehensive assessment of the psychological determinants influencing adherence. The study concludes that the synergistic combination of TAI and IMAS provides a robust, complementary approach, enabling the evaluation of both behavioral and psychosocial dimensions of inhaler adherence. Standardizing and integrating these highly reliable self-report tools into clinical practice in Vietnam could significantly facilitate the development of personalized interventions, optimize treatment efficacy, and ultimately enhance the quality of life for individuals living with COPD.